Clicky

ARCA biopharma, Inc.(ABIO)

Description: ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.


Keywords: Biopharmaceutical Cardiovascular Disease Heart Failure Vascular Disease Dysfunction Heart Disease Atrial Fibrillation Cardiac Arrhythmia Beta Blocker Nuvelo Therapies For Cardiovascular Disease Ventricular Dysfunction

Home Page: www.arcabio.com

ABIO Technical Analysis

10170 Church Ranch Way
Westminster, CO 80021
United States
Phone: 720 940 2200


Officers

Name Title
Dr. Michael R. Bristow M.D., Ph.D. Co-Founder, Pres, CEO & Director
Mr. Thomas A. Keuer Chief Operating Officer
Mr. Christopher D. Ozeroff Sr. VP, Gen. Counsel & Sec.
Mr. C. Jeffrey Dekker CPA Chief Financial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.769
Price-to-Sales TTM: 0
IPO Date: 1997-08-08
Fiscal Year End: December
Full Time Employees: 17
Back to stocks